In the News

GSK and Sanofi join forces to research a vaccine

Graham Watson

15th April 2020

The coronavirus has prompted collaboration in the pharmaceutical sector, with GSK joining forces with Sanofi to develop a series of coronavirus vaccines, and AstraZeneca to increase the UK's coronavirus testing ability.

In remarkable times, joint ventures can help to accelerate innovation ultimately to enhance social welfare. Cooperation between businesses to achieve social aims is not the same as collusive behaviour - something the competition authorities will be keen to stress. That said, the vaccine is likely to remain at least a year off.

Graham Watson

Graham Watson has taught Economics for over twenty years. He contributes to Tutor2U, reads voraciously and is interested in all aspects of Teaching and Learning.

© 2002-2024 Tutor2u Limited. Company Reg no: 04489574. VAT reg no 816865400.